April 2, 2008
Singulair suicide story won't kill Merck
Analysis of:
FDA Investigating Possible Link Between Singulair and Suicide | www.foxnews.com
This analysis is solely the work of the author. It has not been edited or endorsed by GLG.
Implications: Singulair helps millions of people suffering from asthma. While there are a few sporadic cases of suicide and depression among the millions of patients taking singulair, no causal link has been established and there is no clear mechanism of how singulair might even cause such effects. In fact, there were no occurrences of suicide in over 11000 subjects receiving singulair in 40 trials to date. It seems we are dealing with sporadic cases of an unfortunately common problem (suicide) in the setting of a commonly used drug (singulair) for a common disease (asthma). While the data will be reviewed more thoroughly, I suspect that no significant association will be uncovered, that patients will continue taking this drug for asthma, and this story will not have significant effect on Merck sales.
Analysis: Singulair helps millions of people suffering from asthma. While there are a few sporadic cases of suicide and depression among the millions of patients taking singulair, no causal link has been established and there is no clear mechanism of how singulair might even cause such effects. In fact, there were no occurrences of suicide in over 11000 subjects receiving singulair in 40 trials to date. It seems we are dealing with sporadic cases of an unfortunately common problem (suicide) in the setting of a commonly used drug (singulair) for a common disease (asthma). While the data will be reviewed more thoroughly, I suspect that no significant association will be uncovered, that patients will continue taking this drug for asthma, and this story will not have significant effect on Merck sales.
Analysis: Singulair helps millions of people suffering from asthma. While there are a few sporadic cases of suicide and depression among the millions of patients taking singulair, no causal link has been established and there is no clear mechanism of how singulair might even cause such effects. In fact, there were no occurrences of suicide in over 11000 subjects receiving singulair in 40 trials to date. It seems we are dealing with sporadic cases of an unfortunately common problem (suicide) in the setting of a commonly used drug (singulair) for a common disease (asthma). While the data will be reviewed more thoroughly, I suspect that no significant association will be uncovered, that patients will continue taking this drug for asthma, and this story will not have significant effect on Merck sales.
Report a Concern
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Painkiller Risk Found for Heart Patients
www.nytimes.com
FDA Asks if Pain Pill Is Tamper-Proof
online.wsj.com
Merck KGaA: Overall Survival in First-Line NSCLC Reaches 15 Months
www.pipelinereview.com
Hospitals See Drop in Paying Patients
www.nytimes.com
Gardasil, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
www.fiercebiotech.com
Will contact lens solutions cost more to ship and store?
November 13, 2008
Economy's impact on healthcare facilities
November 13, 2008
Tamper Proof Narcotic Pain pill? YES
November 13, 2008
CVS Escalates the Generic Price War
November 13, 2008
A closer look
November 11, 2008

